ABEC Expands Equipment Supply Capability for China’s Biopharmaceutical Manufacturing Industry

ABEC becomes the only biopharmaceutical systems supplier with China Manufacture Licenses on two continents

BETHLEHEM, Pa.--()--ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced that its manufacturing facility in Kells, Co. Meath, Ireland has received certification from the People’s Republic of China as a qualified manufacturer of pressure vessels and components for use in China. ABEC Kells is the second of ABEC’s facilities to obtain its China Manufacture License (CML). ABEC’s Springfield, MO USA facility has held its CML since 2010. ABEC was awarded the CML for its Kells facility after a rigorous audit of its vessel engineering, manufacturing and quality processes by the China Special Equipment Inspection & Research Institute (CSEI).

ABEC has been investing in China for over ten years to support the rapid growth of China’s biotech industry, and pressure vessels are critical components of the systems used to manufacture biopharmaceuticals. The CML for Kells allows ABEC to provide fully-compliant systems from both the US and Europe, ensuring consistent and flexible supply to customers in China, as well as supporting foreign companies who are establishing manufacturing facilities in China.

“By earning the CML for Kells, ABEC continues to demonstrate our long-term commitment to customers in China,” said Scott Pickering, ABEC President and CEO. “We are proud of this achievement and our industry leadership in global code compliance for equipment manufacturing.”

About ABEC

Since 1974, ABEC has been a global leader in delivering integrated process solutions and services for manufacturing in the biopharmaceutical industry. A majority of the world's pharmaceutical and biotech companies are ABEC customers; with many of today's leading therapies manufactured by processes and equipment engineered, manufactured, installed and serviced by ABEC. Whether adding capacity or improving existing facilities, ABEC's turn-key solutions and support services reduce overall cost and time to market while delivering maximum productivity. To learn more about ABEC, visit, http://www.abec.com, http://www.abecsingleuse.com, email info@abec.com and follow us on LinkedIn.

Contacts

ABEC
Susan Curcio, +1 610-861-4666
Director of Marketing
scurcio@abec.com

Release Summary

ABEC Expands Equipment Supply Capability for China’s Biopharmaceutical Manufacturing Industry. ABEC Kells facility obtains China Manufacture License.

Contacts

ABEC
Susan Curcio, +1 610-861-4666
Director of Marketing
scurcio@abec.com